1. As per Regulations 32(1), 32(2) and 32(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR Regulations’), a listed entity is, inter alia, required to submit to the stock exchange, a statement of deviation or variation, pursuant to review by the audit committee, on a quarterly basis for public issue, rights issue, preferential issue etc. indicating, deviations, if any, in the use of proceeds of public issue, rights issue, preferential issue etc. andthe category wise variation between projected utilisation of funds and the actual utilisation of funds.
Such statement of deviation or variation is to be submitted till the issue proceeds have been fully utilised or the purpose for which these proceeds were raised has been achieved.
2. Stock Exchanges, during the course of interactions with SEBI have submitted that while listed entities submit the statement of deviation or variation, there is no uniformity in the formats so submitted. Hence there is a need to introduce a common format for such reporting.
3. Further, such a common format will also aid monitoring by Stock Exchanges, of the end use of issue proceeds raised by listed entities through public issue, rights issue, preferential issue, QIP etc. Hence, for the purpose of compliance with 32(1), 32(2) and 32(3) of the SEBI LODR Regulations, listed entities shall follow the format.
4. The salient features of the format are as under:
a. Applicability: The format shall be applicable for funds raised by listed entities through public issue, rights issue, preferential issue, QIPs etc.
b. Frequency of Disclosure: The disclosure to the Stock Exchange(s) shall be made by listed entities on quarterly basis along with the declaration of financial results (within 45 days of end of each quarter / 60 days from the end of the last quarter of the financial year) until such funds are fully utilised or the purpose for which these proceeds were raised has been achieved.
c. Role of the Audit Committee: The statement of deviation report shall be placed before audit committee of the listed entity for review on quarterly basis and after such review, the comments of audit committee along with the report shall be disclosed/submitted to the stock exchange, as part of the format. In cases where the listed entity is not required to have an audit committee under the provisions of SEBI LODR Regulations or Companies Act, 2013, the word ‘Audit Committee’ shall be replaced with ‘Board of Directors’.
5. The first such submission shall be made by the listed entities for the quarter ending December 31, 2019; subsequent submissions shall be quarterly as explained above.
Statement of Deviation / Variation in utilisation of funds raised
Name of listed entity | ||||||
Mode of Fund Raising | Public Issues / Rights Issues / Preferential Issues / QIP / Others | |||||
Date of Raising Funds | ||||||
Amount Raised | ||||||
Report filed for Quarter ended | ||||||
Monitoring Agency | applicable / not applicable | |||||
Monitoring Agency Name, if applicable | ||||||
Is there a Deviation / Variation in use of funds raised | Yes / No | |||||
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders | ||||||
If Yes, Date of shareholder Approval | ||||||
Explanation for the Deviation / Variation | ||||||
Comments of the Audit Committee after review | ||||||
Comments of the auditors, if any | ||||||
Objects for which funds have been raised and where there has been a deviation, in the following table | ||||||
Original Object | Modified Object, if any | Original Allocation Modified a | Modified allocation, if any | Funds Utilised | Amount of Deviation/Variation for the quarter according to applicable object | Remarks if any |
Deviation or variation could mean:
(a) Deviation in the objects or purposes for which the funds have been raised or
(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or
(c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc
Name of Signatory
Designation